Treatment for Thyroid Cancer and other Endocrine Cancers
At Hackensack Meridian Health, our dedicated team of endocrine surgeons, endocrinologists, and specialists use cutting-edge diagnostic techniques and treatments to provide personalized care for thyroid cancer and other endocrine cancers. Our goal is to offer the best possible treatment outcomes with state-of-the-art care.
Diagnosing and Staging Thyroid and Endocrine Cancer
Accurate diagnosis and staging are essential for developing the right treatment plan. Common diagnostic tests for thyroid and endocrine cancers include:
Measures calcium and other substances released by organs and tissues.
Evaluates hormone levels in the body.
Creates detailed cross-sectional images of the body to identify tumors.
Examines vocal cord function to detect abnormalities.
Uses magnetic fields and radio waves to produce images of tumors and assess their spread.
Identifies the size and nature (solid or cystic) of thyroid nodules.
Thyroid and Endocrine Cancer Treatment Options
Our multidisciplinary team collaborates to develop a personalized treatment plan based on your specific needs. Treatment options for thyroid cancer and other endocrine cancers include:
Surgeons use small incisions and video-assisted scopes to remove part or all of a gland or tumor, leading to quicker healing and reduced scarring.
For larger thyroid cancers, a radioactive pill is administered post-surgery to destroy remaining cancer cells without harming surrounding tissues.
For smaller thyroid cancers, surgery may be the sole treatment.
For certain thyroid and adrenal cancers, chemotherapy or targeted therapies may be used. Our specialists select therapies based on the genetic mutations and molecular structure of the tumor.
Our Research and Clinical Trials
At Hackensack Meridian Health, you may have the opportunity to participate in a clinical trial of new and exciting approaches to stem cell transplant. Our research has a strong focus on reducing the complications of transplant and also lowering the risk of disease recurrence. We are the first in the world to combine checkpoint inhibitors (drugs that inhibit the proteins cancer cells use to evade detection by the immune system) after transplantation, at a time when the immune system has the best opportunity to eliminate any remaining cancer cells.
